1. Home
  2. PHAT vs PDS Comparison

PHAT vs PDS Comparison

Compare PHAT & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • PDS
  • Stock Information
  • Founded
  • PHAT 2018
  • PDS 1951
  • Country
  • PHAT United States
  • PDS Canada
  • Employees
  • PHAT N/A
  • PDS N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • PDS
  • Sector
  • PHAT Health Care
  • PDS
  • Exchange
  • PHAT Nasdaq
  • PDS Nasdaq
  • Market Cap
  • PHAT 1.2B
  • PDS 998.3M
  • IPO Year
  • PHAT 2019
  • PDS N/A
  • Fundamental
  • Price
  • PHAT $8.78
  • PDS $62.23
  • Analyst Decision
  • PHAT Strong Buy
  • PDS Buy
  • Analyst Count
  • PHAT 4
  • PDS 1
  • Target Price
  • PHAT $22.50
  • PDS $95.00
  • AVG Volume (30 Days)
  • PHAT 1.9M
  • PDS 101.6K
  • Earning Date
  • PHAT 11-07-2024
  • PDS 10-29-2024
  • Dividend Yield
  • PHAT N/A
  • PDS N/A
  • EPS Growth
  • PHAT N/A
  • PDS 62.11
  • EPS
  • PHAT N/A
  • PDS 12.37
  • Revenue
  • PHAT $26,270,000.00
  • PDS $1,436,787,445.00
  • Revenue This Year
  • PHAT $6,714.96
  • PDS $4.34
  • Revenue Next Year
  • PHAT $293.69
  • PDS $3.31
  • P/E Ratio
  • PHAT N/A
  • PDS $4.87
  • Revenue Growth
  • PHAT N/A
  • PDS N/A
  • 52 Week Low
  • PHAT $6.07
  • PDS $49.67
  • 52 Week High
  • PHAT $19.71
  • PDS $79.07
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 23.73
  • PDS 50.03
  • Support Level
  • PHAT $8.91
  • PDS $61.92
  • Resistance Level
  • PHAT $19.05
  • PDS $65.15
  • Average True Range (ATR)
  • PHAT 1.74
  • PDS 2.12
  • MACD
  • PHAT -1.05
  • PDS 0.35
  • Stochastic Oscillator
  • PHAT 2.19
  • PDS 62.13

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About PDS Precision Drilling Corporation

Precision Drilling Corpd is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

Share on Social Networks: